These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1385599

  • 1. Facet theoretic analysis of the Hamilton-D scale.
    Steinmeyer EM, Möller HJ.
    J Affect Disord; 1992 May; 25(1):53-61. PubMed ID: 1385599
    [Abstract] [Full Text] [Related]

  • 2. [Clinical validity of the Beck Depression Inventory. A facet theoretical re-analysis of multicenter clinical observations].
    Steinmeyer EM.
    Nervenarzt; 1993 Nov; 64(11):717-26. PubMed ID: 8278012
    [Abstract] [Full Text] [Related]

  • 3. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H, Rudolf GA.
    Acta Psychiatr Scand Suppl; 1989 Nov; 350():145-6. PubMed ID: 2530773
    [No Abstract] [Full Text] [Related]

  • 4. Antidepressants and the peripheral nervous system.
    Husstedt IW, Kuhs H, Rudolf GA, Brune GG.
    Acta Psychiatr Scand Suppl; 1989 Nov; 350():147-8. PubMed ID: 2530774
    [No Abstract] [Full Text] [Related]

  • 5. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
    Laursen AL, Mikkelsen PL, Rasmussen S, le Fèvre Honoré P.
    Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
    [Abstract] [Full Text] [Related]

  • 6. Facet theory applied to the construction and validation of the Aachen Aphasia Test.
    Willmes K, Poeck K, Weniger D, Huber W.
    Brain Lang; 1983 Mar; 18(2):259-76. PubMed ID: 6839143
    [Abstract] [Full Text] [Related]

  • 7. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L.
    Acta Psychiatr Scand Suppl; 1989 Mar; 350():141-2. PubMed ID: 2530771
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E, Pelicier Y, Archambault JC, Chabannes JP, Clerc G, Desvilles M, Guibert M, Pagot R, Poisat JL, Thobie Y.
    Acta Psychiatr Scand Suppl; 1989 Mar; 350():132-4. PubMed ID: 2530766
    [No Abstract] [Full Text] [Related]

  • 9. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP, Kuhs H, Rolf LH, Bosse T, Schuhknecht E, Rudolf GA, Brune GG.
    Acta Psychiatr Scand Suppl; 1989 Mar; 350():149-51. PubMed ID: 2530775
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM, Naylor GJ, Murtagh M, Winslow G.
    Acta Psychiatr Scand Suppl; 1989 Mar; 350():143-4. PubMed ID: 2530772
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC, Cohn JB, Fabre LF, Feighner JP, Fieve RR, Mendels J, Shrivastava RK.
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():138-9. PubMed ID: 2530768
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
    Kuhs H, Schlake HP, Rolf LH, Rudolf GA.
    Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
    [Abstract] [Full Text] [Related]

  • 14. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN, Yiptong C, Samsoon J, Schulsinger F, Fabricius J.
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [Abstract] [Full Text] [Related]

  • 15. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA, Müller PG, Fourie J, Le Roux JF.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():130-1. PubMed ID: 2530765
    [No Abstract] [Full Text] [Related]

  • 16. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC, Kaye CM, Zussman BD, Link CG.
    Acta Psychiatr Scand Suppl; 1989 Sep; 350():152-5. PubMed ID: 2530776
    [No Abstract] [Full Text] [Related]

  • 17. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.
    Skrumsager BK, Jeppesen K.
    Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871
    [Abstract] [Full Text] [Related]

  • 18. Recovery from depression: triggers and time patterns.
    Parker G.
    Aust N Z J Psychiatry; 1996 Aug; 30(4):442-4. PubMed ID: 8887691
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C, Pintens H.
    Acta Psychiatr Scand Suppl; 1989 Aug; 350():140. PubMed ID: 2530770
    [No Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of paroxetine.
    Kuhs H, Rudolf GA.
    Psychopharmacology (Berl); 1990 Aug; 102(3):379-82. PubMed ID: 2147517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.